HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
VTVT
vTv Therapeutics Inc.
There isn't enough reported data to score VTVT yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
VTVT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
VTVT's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
VTVT PE Valuation
VTVT has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
VTVT Forward outlook
There aren't enough analyst estimates for VTVT to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
VTVT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.11 | +$3.09 |
| Q1 2026 | $0.02 | +$3.11 |
| Q4 2025 | -$3.62 | -$0.13 |
| Q3 2025 | -$3.40 | +$1.13 |
| Q2 2025 | -$3.20 | +$3.72 |
| Q1 2025 | -$3.09 | +$5.78 |
| Q4 2024 | -$3.49 | +$6.42 |
| Q3 2024 | -$4.53 | +$6.04 |
VTVT has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over VTVT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
VTVT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2022 | $9K | 0% |
| Q2 2022 | $9K | 0% |
| Q1 2022 | $2M | +103% |
| Q4 2021 | $9K | -100% |
| Q3 2021 | $3M | +42757% |
| Q1 2021 | $987K | +12238% |
| Q4 2020 | $6.4M | +91314% |
VTVT's revenue is growing: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | 63% | N/A |
| Q4 2024 | -28776% | N/A |
| Q1 2024 | -563% | N/A |
| Q4 2022 | -70478% | +52956 points |
| Q2 2022 | -44744% | +7144 points |
| Q1 2022 | -324% | +110 points |
| Q4 2021 | -123433% | -123462 points |
| Q3 2021 | -53% | +40404 points |
VTVT's operating margin was 63% last quarter, up 44808 points from the same quarter a year ago, near the top of its range since 2019.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over VTVT on cash generation, producing positive trailing cash flow while its opponent burns cash.
VTVT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$10.2M | -$5M |
| Q2 2026 | -$11.4M | -$6.3M |
| Q1 2026 | $9.2M | +$14.8M |
| Q4 2025 | -$9.3M | -$4.4M |
| Q3 2025 | -$5.2M | +$1.2M |
| Q2 2025 | -$5.1M | +$1.6M |
| Q1 2025 | -$5.7M | +$1.6M |
| Q4 2024 | -$4.8M | -$1.9M |
VTVT has burned cash in almost every quarter: −$22M over the past year, against −$21M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over VTVT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
VTVT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +47% | +4M shares |
| 1 year | +88% | +5.8M shares |
| 3 years | +509% | +10.4M shares |
| 5 years | +747% | +10.9M shares |
| Available history | +1208% | +11.5M shares |
VTVT has 12M diluted shares, up 88% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
VTVT hasn't bought back shares in the past year.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
VTVT Net Leverage
VTVT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
VTVT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 3.6 | Oversold |
VTVT's weekly RSI is 31 (neutral) and its Stochastic is 4 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
VTVT PE vs Healthcare Sector
| Metric | VTVT | Sector median | Relative |
|---|---|---|---|
| PE | 1,559x | 26x | 5,931% above |
| PE % | 19 | 29 | 10 pts below |
VTVT has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
VTVT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.4 | 22% below |
| 20 week MA | $30.2 | 31% below |
| 50 week MA | $33.0 | 37% below |
| 100 week MA | $25.8 | 20% below |
| 200 week MA | $23.5 | 12% below |
VTVT is in a downtrend: it's below all five of its weekly moving averages, and 12% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over VTVT on returns for 2026, with the stronger performance.
VTVT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $71.6 | $82.0 | +15% |
| 2021 | $82.0 | $43.2 | -47% |
| 2022 | $43.2 | $27.2 | -37% |
| 2023 | $27.2 | $11.5 | -58% |
| 2024 | $11.5 | $13.2 | +15% |
| 2025 | $13.2 | $37.9 | +187% |
| 2026 YTD | $37.9 | $20.7 | -45% |
VTVT's yearly returns have swung widely, from +187% in 2025 to −58% in 2023. It's down 45% so far in 2026.